Pasqualina Mazzu

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults

Michel Moutschen, Philippe Léonard, Étienne Sokal et al. · Vaccine · 2007 · 173 citations

Vaccination, Vaccine Safety, Vaccine Development +9

Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model

Michèle Haumont, Louis Delhaye, Lida Garcia et al. · Infection and Immunity · 2000 · 72 citations · Full text

Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells

Michèle Haumont, Alain Jacquet, Marc Massaer et al. · Virus Research · 1996 · 44 citations

Vaccination, Molecular Virology, Pathogenesis +4

High-Level Expression in Mammalian Cells of Recombinant House Dust Mite Allergen ProDer p 1 with Optimized Codon Usage

Marc Massaer, Pasqualina Mazzu, Michèle Haumont et al. · International Archives of Allergy and Immunology · 2001 · 41 citations

Immunogenicity of a recombinant varicella-zoster virus gE–IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

Alain Jacquet, Michèle Haumont, Marc Massaer et al. · Vaccine · 2002 · 17 citations

Vaccination, Vaccine Development, Viral Pathogenesis +8